Short Interest in The Oncology Institute, Inc. (NASDAQ:TOI) Decreases By 86.0%

The Oncology Institute, Inc. (NASDAQ:TOI) saw a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 173,500 shares, a decrease of 86.0% from the November 30th total of 1,240,000 shares. Based on an average trading volume of 1,640,000 shares, the short-interest ratio is presently 0.1 days. Currently, 0.5% of the shares of the stock are short sold.

Insider Activity

In related news, Director Brad Hively purchased 250,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The shares were bought at an average cost of $0.17 per share, with a total value of $42,500.00. Following the acquisition, the director now owns 616,753 shares of the company’s stock, valued at $104,848.01. This represents a 68.17 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. 9.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in TOI. HighTower Advisors LLC raised its stake in Oncology Institute by 190.8% during the 3rd quarter. HighTower Advisors LLC now owns 81,362 shares of the company’s stock worth $27,000 after acquiring an additional 53,382 shares during the period. Renaissance Technologies LLC raised its position in shares of Oncology Institute by 142.3% during the second quarter. Renaissance Technologies LLC now owns 339,400 shares of the company’s stock valued at $156,000 after buying an additional 199,300 shares during the last quarter. Finally, Tiff Advisory Services LLC lifted its holdings in shares of Oncology Institute by 235.1% in the second quarter. Tiff Advisory Services LLC now owns 1,418,685 shares of the company’s stock worth $653,000 after buying an additional 995,280 shares in the last quarter. Institutional investors own 36.86% of the company’s stock.

Oncology Institute Trading Up 15.3 %

TOI traded up $0.03 during trading on Thursday, hitting $0.26. 369,475 shares of the stock traded hands, compared to its average volume of 538,060. Oncology Institute has a 12-month low of $0.13 and a 12-month high of $2.50. The firm has a market capitalization of $19.46 million, a P/E ratio of -0.33 and a beta of 0.43. The firm has a 50-day moving average of $0.24 and a 200 day moving average of $0.35. The company has a debt-to-equity ratio of 5.91, a current ratio of 2.49 and a quick ratio of 2.27.

About Oncology Institute

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.